Economic value of ribociclib in early breast cancer in the United States
- DOI
- 10.18553/jmcp.2026.32.8.911
- Published
- 2026-08
- Container
- Journal of Managed Care & Specialty Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.18553/jmcp.2026.32.8.911,
title = {Economic value of ribociclib in early breast cancer in the United States},
author = {Adam Brufsky and Sara M. Tolaney and Vijayakrishna K. Gadi and Xinglei Chai and Fan Yang and Weiye Chen and Wenxin Ma and Zheng-Yi Zhou and Vaidyanathan Ganapathy and Apeksha Patel and Gary Sopher and Emma Alexander and Vamsi Bollu and Louis P. Garrison and Joseph A. Sparano},
year = {2026},
journal = {Journal of Managed Care \& Specialty Pharmacy},
doi = {10.18553/jmcp.2026.32.8.911},
url = {https://doi.org/10.18553/jmcp.2026.32.8.911}
}RIS
TY - JOUR TI - Economic value of ribociclib in early breast cancer in the United States AU - Adam Brufsky AU - Sara M. Tolaney AU - Vijayakrishna K. Gadi AU - Xinglei Chai AU - Fan Yang AU - Weiye Chen AU - Wenxin Ma AU - Zheng-Yi Zhou AU - Vaidyanathan Ganapathy AU - Apeksha Patel AU - Gary Sopher AU - Emma Alexander AU - Vamsi Bollu AU - Louis P. Garrison AU - Joseph A. Sparano PY - 2026 JO - Journal of Managed Care & Specialty Pharmacy DO - 10.18553/jmcp.2026.32.8.911 UR - https://doi.org/10.18553/jmcp.2026.32.8.911 ER -
APA
Brufsky, A., Tolaney, S. M., Gadi, V. K., Chai, X., Yang, F., Chen, W., Ma, W., Zhou, Z., Ganapathy, V., Patel, A., Sopher, G., Alexander, E., Bollu, V., Garrison, L. P., & Sparano, J. A. (2026). Economic value of ribociclib in early breast cancer in the United States. Journal of Managed Care & Specialty Pharmacy. https://doi.org/10.18553/jmcp.2026.32.8.911
Source records
- crossref · retrieved 2026-09-26T01:50:16.523Z